AXIM BIOTECHNOLOGIES, INC.: 10-Q filed 2017-11-20
What AXIM BIOTECHNOLOGIES, INC. reported in its quarterly report filed 2017-11-20 (fiscal Q3 2017): 34 published measures, 95 facts as tagged in accession 0001078782-17-001610.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-11-20
- Fiscal period
- fiscal Q3 2017
- Accession
- 0001078782-17-001610 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AXIM BIOTECHNOLOGIES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 3,321,999 | USD | |
| At 2016-12-31 | 1,449,172 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 8,174,378 | USD | |
| At 2016-12-31 | 3,820,761 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 3,081,511 | USD | |
| At 2016-12-31 | 713,346 | USD | |
| At 2016-09-30 | 870,633 | USD | |
| At 2015-12-31 | 134,170 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -1,641,701 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -2,730,589 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -1,783,641 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -4,626,317 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 9,758 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 32,116 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 9,600 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 34,846 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 4,434,457 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 1,498,157 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 0 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 0 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -20,800,225 | USD | |
| At 2016-12-31 | -18,069,636 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 0 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 0 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 0 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 0 | USD | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 9,788 | USD | |
| At 2016-12-31 | 12,305 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 50,300 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 1,424,935 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -1,185,047 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -2,098,611 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -1,555,572 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -2,989,239 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 3,241,604 | USD | |
| At 2016-12-31 | 1,373,700 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 111,891 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 178,944 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 225,382 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 249,391 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 6,726,349 | USD | |
| At 2016-12-31 | 3,016,828 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 63,167 | USD | |
| At 2016-12-31 | 63,167 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 1,193,161 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 2,088,667 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 1,551,511 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 2,983,128 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 16,527 | USD | |
| At 2016-12-31 | 38,446 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 8,114 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -9,944 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -4,061 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -6,111 | USD | 274 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 1,644 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 42,060 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 13,661 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 40,957 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 632,674 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 835,988 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 87,718 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 163,946 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 54,564,441 | shares | |
| At 2016-12-31 | 52,506,441 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 15,923,789 | USD | |
| At 2016-12-31 | 15,672,631 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | -4,852,379 | USD | |
| At 2016-12-31 | -2,371,589 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 6,991 | USD | |
| At 2016-12-31 | 4,474 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-09-30 | 63,167 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -1,641,701 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -2,730,589 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -1,783,641 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -4,626,317 | USD | 274 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -2,730,589 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -4,626,317 | USD | 274 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -1,641,701 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -2,730,589 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -3,258,641 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -6,101,317 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | 559,648 | USD | 92 |
| 2017-01-01 to 2017-09-30 | 1,250,162 | USD | 273 |
| 2016-07-01 to 2016-09-30 | 1,462,954 | USD | 92 |
| 2016-01-01 to 2016-09-30 | 2,816,666 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 2,517 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 2,516 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-07-01 to 2017-09-30 | -456,654 | USD | 92 |
| 2017-01-01 to 2017-09-30 | -631,978 | USD | 273 |
| 2016-07-01 to 2016-09-30 | -228,069 | USD | 92 |
| 2016-01-01 to 2016-09-30 | -1,637,078 | USD | 274 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | 0 | USD | 273 |
| 2016-01-01 to 2016-09-30 | 0 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-09-30 | -21,919 | USD | 273 |
| 2016-01-01 to 2016-09-30 | -39,973 | USD | 274 |
Inspect the source
- Entity
- AXIM BIOTECHNOLOGIES, INC. / CIK 0001514946
- Captured
- 2026-09-20T09:13:30.666Z
- SEC response SHA-256
5755093e2dfb1c20119737eacb251a5ef040e09cdc537c89d6edf9272249749e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001514946.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))